iStock Rating

B

Details...

Enter Symbol

Exactech, Inc. (NASDAQ: EXAC)

Sector: Medical

Current Price : $18.17

52 Week Low
$15.1452 Week High
$20.76

Company

Company Profile

Community

Stock Sentiment

Whisper Estimates

Enter Estimates

Analysis

Charts

Technical Charts

Analyst

Analyst Ratings

Analyst Estimates

Sales Estimates

Ratios

Financial Ratios

Shares Outstanding: 13M
Market Cap: $0.26B
Avg Volume: 23658
P/E Ratio: 20.290
PEG Ratio: -0.010
Split: On 3/3/2003 exac split by factor of 2.000

exac three month chart

exac three month chart

exac six month chart

exac one year chart

exac two year month chart

Opinion and Analysis

Medical Supply Stocks To Get Hit By The Taxman, Yeah, The Taxman
Dec 07, 2012 09:51 AM | ALOG, BRKR, CEMI, CHDX, CNMD, CRY
Retail In The Spotlight
Feb 22, 2010 11:57 AM | AAWW, ADLR, ADSK, AER, AFAM, AMED
Bookkeeping: Initating Position in Thoratec and Adding to Other Healthcare
Sep 03, 2008 11:34 AM | EXAC, LSR, THOR
More Articles on EXAC..

Press Releases

Exactech Launches Gibralt? OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offering Spinal Fusion Solutions For The Entire Spine
May 06, 2013 09:45 AM | EXAC
Exactech Q1 Net Income up 17% to $3.8 Million; Diluted EPS $.29 vs. $.25; Worldwide Sales Up 1% to $59.3 Million; U.S. Sales Increased 6%
Apr 23, 2013 04:01 PM | EXAC
Exactech Schedules First Quarter 2013 Earnings Release and Conference Call
Apr 16, 2013 11:34 AM | EXAC
More Press Releases on EXAC..

SEC Filings

Form 4 EXACTECH INC For: Mar 06 Filed by: PETTY R WILLIAM (10K)
Mar 08, 2013 05:19 PM
Form 4 EXACTECH INC For: Mar 06 Filed by: PETTY BETTY A (10K)
Mar 08, 2013 05:19 PM
Form 4 EXACTECH INC For: Mar 06 Filed by: MILLER GARY J (10K)
Mar 08, 2013 05:18 PM

Sentiment Survey

Avg. Short Term

Avg. Long Term

Avg. Grade

More Details

Share Performance

Period	EXAC	Compare to S&P
YTD	14.93 %	5.39 %
4 Weeks	-1.72 %	-1.61 %
12 Weeks	3.62 %	0.13 %
More...

Financial Ratios

exac Financial Ratios Chart

Earnings Performance

EPS Growth in Last Quarter: 52.63 %

EPS Growth in Last Year: 61.11 %

Sales Growth in Last Quarter: 15.57 %

Sales Growth in Last Quarter: 11.66 %

More...

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.